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ABSTRACT  
A clinically actionable understanding of multiple sclerosis (MS) etiology goes through GWAS 
interpretation, prompting research on new gene regulatory models. Our previous works on these 
topics suggested a stochastic etiologic model where small-scale random perturbations could 
eventually reach a threshold for MS onset and progression. A new sequencing technology has 
mapped the transient transcriptome (TT), including intergenic RNAs, and antisense intronic RNAs. 
Through a rigorous colocalization analysis, here we show that genomic regions coding for the TT 
were significantly enriched for both MS-associated GWAS variants, and DNA binding sites for 
molecular transducers mediating putative, non-genetic, etiopathogenetic factors for MS (e.g., 
vitamin D deficiency, Epstein Barr virus latent infection, B cell dysfunction).  
These results suggest a model whereby TT-coding regions are hotspots of convergence between 
genetic ad non-genetic factors of risk/protection for MS (and plausibly for other complex disorders). 
Our colocalization analysis also provides a freely available data resource at www.mscoloc.com for 
future research on transcriptional regulation in MS. 
GRAPHICAL ABSTRACT 
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INTRODUCTION  
A large body of literature agrees that regulatory genomic intervals, especially those encompassing 
enhancers, are enriched with disease-associated DNA elements. Most of this evidence comes 
from genome wide association studies (GWAS) based on single polymorphism nucleotides (SNPs) 
representing common variants,1-5 even though a recent study showed that low-frequency and rare 
coding variants may somewhat contribute to MS heritability.6 Several characteristics of regulatory 
disease-associated genetic variants complicates GWAS interpretation, prompting research on new 
gene regulatory models: (i) SNPs are chosen as haplotypes to spare the genotyping work needed 
for the large number of samples used in GWAS, therefore fine mapping and epigenetic studies are 
required to integrate GWAS data;7-10 (ii) only a small fraction of supposedly causal disease-
associated variants directly alters recognizable transcription factor binding motifs as it might be 
expected, according to their regulatory function;4 (iii) the identified GWAS signals are likely to exert 
highly contextual (i.e., time- and position-dependent) regulatory effects, that may change according 
to the tissue and to the time when they receive an input from inside or outside the cell. In 
summary, current gene regulatory models help only in part to fully detail which disease-associated 
SNP signals are causal, and by which exact mechanisms they are causal. Recent studies on the 
biological spectrum of human DNase I hypersensitive sites (DHSs), that are disease-associated 
markers of regulatory DNA, may help to better rework GWAS data and particularly to contextualize 
the genomic variants according to tissue/cell states and to gene body colocalization of DHSs.11 In 
this context, the latest version of the Genotype-Tissue Expression project may provide further 
insights into the tissue specificity of genetic effects, supporting the link between regulatory 
mechanisms and traits or complex diseases.12 
Another layer of complexity is revealed by our recent studies suggesting an MS etiologic model 
where stochastic phenomena (i.e., random events not necessarily resulting in disease in all 
individuals) may contribute to the disease onset and progression. This model, embedded between 
physics of stochastic systems and cell biology, suggests how small-scale random perturbations 
would impact on large-scale phenomena, such as disease development. Such perturbations would 
allow to exceed the onset threshold that is believed to be set by genetic and non-genetic 
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susceptibility factors such as microbial or geographical characteristics.13, 14 Such model is 
consistent with our previous results that showed heterogeneity in the MS etiology components in 
twin pairs studies.15-17 This is also in line with prior bioinformatics analyses that determined a 
significant enrichment of binding motifs for Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) 
and vitamin D receptor (VDR) in genomic regions containing MS-associated GWAS variants.18 We 
also demonstrated that genomic variants of EBNA2 resulted to be MS-associated,19 and other 
groups have further developed our findings showing that enrichment of EBNA2-binding regions on 
GWAS DNA intervals is involved in the pathogenesis of autoimmune disorders, including MS.20  
A recent sequencing innovation (called TT-seq) allowed to map the transient transcriptome that 
has a typical half-life within minutes, compared to stable RNA elements, such as protein-coding 
mRNAs, long-noncoding RNAs, and micro-RNAs, that persists at least a few hours.21-23 The 
transient transcriptome (TT) includes mostly enhancer RNAs (eRNA), short intergenic non-coding 
RNAs (sincRNA; i.e. promoter-associated RNAs within 10 kb of a GENCODE mRNA transcription 
start site), and antisense RNAs (asRNA). Such TT elements present specific features, some 
similar to and some contrasting those of stable RNAs. More in detail, transient RNAs (trRNA) are 
relatively short in length, they generally lack a secondary structure, and would not present those 
chemical modifications that characterize unidirectional and polyadenylated stable RNAs.21, 24, 25 
Other recent works based on time-resolved analysis, agree on the eRNAs very rapid functional 
dynamics model while interacting with the transcriptional co-activator acetyltransferase CBP/p300 
complex.26, 27 This confirms the highly contextual role of eRNAs through the control of transcription 
burst frequencies, which are known to influence cell-type-specific gene expression profiles.28 Along 
these lines, a recent study showed that T cells selectively filter oscillatory signals within the minute 
timescale,29 further supporting the aforementioned model. 
In summary, on the basis of our previous research (i.e., the heterogeneity in the MS etiology 
components; the stochasticity in the interaction between genetic and non-genetic factors 
contributing to disease development; the enrichment of binding sites for environmental factors in 
MS-associated DNA intervals) and leveraging the recent sequencing innovations in the mapping of 
the transient transcriptome (i.e., the erratic time dynamics and the highly contextual expression),21, 
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22 we hypothesize that MS-associated GWAS signals prevalently fall within regulatory regions of 
DNA coding for transient RNAs (trRNA). In theory, the genomic intervals coding for the transient 
transcriptome may be the hotspots where temporo-spatial occurrences (stochastic in nature, as 
said) may coalesce and so contribute to physiological outcomes (that similarly present as 
developmental and/or adaptive), or possibly give rise to MS onset or progression. This study is 




MS GWAS and trRNAs - MS-associated GWAS signals colocalize with regulatory regions of 
DNA plausibly coding for trRNAs 
We set up our region-of-interest (ROI) inside GWAS catalogue30 by considering all MS GWAS that 
were published, extracting all SNP positions, and creating a single set of genomic coordinates that 
therefore encompass all GWAS-derived or GWAS-verified signal for MS. We then refined the SNP 
list by pruning out about 1.5% of the SNPs as they did not contain intelligible genomic annotations 
or were duplicates. The final ROI list is reported in Supplementary Table 1 and consists of 603 
unique single-nucleotide regions. 
Next, we matched through colocalization analyses our ROI with lists of regions resulting from the 
work by Michel et al., which mapped the transient and stable transcriptome captured by TT-seq 
after T cell stimulation.21 We found a significant enrichment of MS-associated genetic variants in 
the transient transcriptome (Tab. 1). Of note, when we split the transcriptome list in two subsets for 
long (≥ 60 minutes) and short (< 60 minutes) half-life, we found that only the short half-life subset 
significantly colocalized with the ROI. This finding was indicative of the relationship between MS-
associated GWAS signals and the regulatory regions of DNA coding for trRNA.  
When we further dissected the mapping of the ROI colocalization signals, we found a significant 
excess of intergenic and intron regions (as anticipated), as well as their prevalent distribution away 
from the transcription start site (TSS; Fig. 1A). Notably, when we extended this analysis to GWAS 
data coming from other multifactorial diseases or traits, dividing immune-mediated and other 
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complex conditions, we found highly comparable profiles (Fig. 1B, C; Supplementary Table 2). This 
suggests that the colocalization between MS-associated DNA intervals and intergenic or intronic 
sequences, plausibly referring to tr-RNA coding regions, is shared by the genetic architecture of 
most multifactorial disorders. 
To consolidate this result and gain a deeper biological insight, we extended the colocalization 
analysis matching the ROI with a vast set of databases of regulatory DNA regions, including 
enhancers and super-enhancers, derived from experiments on diverse tissue types (references in 
Supplementary Table 3). To improve interpretability of the results through ranking, we 
implemented a harmonic score, based on the Odd Ratio, the -log(p-value), and the support of 
each match. Statistically significant results came from sets included in SEA, seDB, dbSuper and 
other single lists of enhancers and non-coding RNAs (Fig. 2). Interestingly, we found a strong 
enrichment of MS-associated genetic variants in cell lines of hematopoietic lineage, including 
CD19+ and CD20+ B lymphocytes, CD4+ T helper cells, and CD14+ monocytes. Moreover, 
among the top-scoring hits, we found microglial-specific enhancers, which is in line with recent 
reports on brain cell type-specific enhancer–promoter interactome activities and the latest 
GWAS on MS genomic mapping31, 32. On the other hand, non-relevant tissues serving as 
controls (such as kidney, muscle, glands, etc.) scored low in the ranking, crowding the bottom-
left corner of Figure 2. Given the cell-specificity of the action of regions encoding for eRNA and 
other non-coding RNAs, these results are consistent with a functional relevance of GWAS 
variants in contributing to MS disease mechanisms, by modulating transcription regulation. The 
whole list of results derived from ROI and databases matches is freely available as a data 
resource at www.mscoloc.com to support future research on the actors of transcription 
regulation in MS. 
 
TrRNAs and DBRs - Genetic and non-genetic factors for MS etiology converge in genomic 
regions plausibly coding for the transient transcriptome 
Independent studies support the fact that MS GWAS intervals are enriched with DNA binding 
regions (DBRs) for protein ‘transducers’ mediating non-genetic factors of putative etiologic 
.CC-BY-NC-ND 4.0 International licensemade available under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is 
The copyright holder for this preprintthis version posted March 13, 2021. ; https://doi.org/10.1101/2021.03.12.434773doi: bioRxiv preprint 
relevance in MS, such as vitamin D deficiency or EBV latent infection.18, 20 Therefore we further 
inquired whether DNA regions plausibly coding for trRNA share these features (i.e., they colocalize 
with such DRBs). We set up the DBRs for vitamin D receptor (VDR), activation-induced cytidine 
deaminase (AID), Epstein Barr nuclear antigen 2 (EBNA2), Epstein Barr nuclear antigen 3 
(EBNA3C), chosen among viral or host’s nuclear factors potentially associated to MS 
etiopathogenesis.33-36 The DBRs for each nuclear factor were derived from recent literature 
(Supplementary Table 4) and matched with the GWAS-derived MS signals to confirm and expand 
previous results. We found statistically significant results for VDR, EBNA2, and AID for all the SNP 
position extensions (±50, 100, 200 kb), while for EBNA3C significant results came out at extension 
of ±100 and 200 kilobases. This finding suggests that several DBRs are capable of impacting on 
the MS-associated DNA intervals through colocalization (Tab. 2). Notably, when we searched for 
MS-associated regions shared by the DBRs analyzed, we were able to prioritize 275 genomic 
regions capable of binding at least 2 molecular transducers which represent almost half of the MS-
associated GWAS SNPs. These regions are ‘hotspots’ of interactions between genetic and non-
genetic modifier of MS risk/protection. Moreover, all four proteins (VDR, AID, EBNA2, EBNA3C) 
proved to target 24 regions, 3 of them 115 regions, and 2 of them 136 regions (Fig. 3). This data is 
available at www.mscoloc.com, detailing the genomic regions targeted by each of the four 
molecular transducers.  
Building once again on the work by Michel et al.22, we inquired whether there was a colocalization 
between genomic regions containing MS-associated variants, DBRs for VDR, EBNA2, EBNA3C, 
AID, and DNA intervals plausibly coding for trRNA. To this end, we considered the transient 
transcriptome that proved to be enriched with MS-associated variants (Tab. 1), and we then 
matched the corresponding coding regions with the DBRs for the four molecular transducers (for 
this analysis DBRs for EBNA2, EBNA3C, AID and VDR represented the ROI, while the ENCODE 
database of Transcription Factors Binding Sites served as control; Fig. 4). We report the results of 
this analysis in table 3, which shows the colocalization between DNA regions plausibly coding for 
trRNA of both MS-relevant GWAS signals, and DBR of 3 out of 4 factors active at nuclear level, 
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and potentially associated to the disease. The fourth DBR, EBNA3C, did not reach statistical 
significance, though it showed higher values of support for short half-life transcripts. 
 
DBRs and MS GWAS - Genomic regions plausibly coding for the transient transcriptome 
colocalize with MS-associated GWAS signals 
To review and confirm previous colocalizations, we considered the genomic regions resulting from 
the above reported match between the MS-associated GWAS intervals and the databases of 
regulatory DNA regions, containing enhancers and super-enhancers, plausibly enriched in trRNA-
coding sequences (see results in Fig. 2 and the web resource). We therefore matched these DNA 
regions with the DBR for VDR, EBNA2, EBNA3C and AID, finding significant enrichments that 
allow to contextualize and prioritize genomic positions, cell/tissue identity or cell status associated 
to MS. Considering the harmonic score obtained from these colocalization analyses, the top hits 
in EBNA2, EBNA3C, and AID involved lymphoid (CD19+ B cell lines and lymphomas, T 
regulatory cells, tonsils) and monocyte-macrophage lineages (peripheral macrophages, 
dendritic cells) from experiments included in the ENCODE, dbsuper, roadmapEpigenomics 
databases (see also Supplementary Table 5). Even though immune cells prevailed also in VDR 
top hits, a less stringent polarization was seen, somehow reflecting the wide-spreading actions 
of this transducer in human biology. However, with a more stringent cutoff of harmonic score >40 
that selects the most significant hits (Supplementary Fig.1), a core subset of MS-relevant cell 
lineages, shared across all four examined transducers, became evident (Supplementary Table 6). 
These data and results are available in full at www.mscoloc.com.  
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DISCUSSION  
Our study supports the hypothesis that investigations on the transient transcriptome may 
contribute to clarify how the GWAS signals affect the etiopathogenesis of MS and possibly of other 
complex disorders. Specifically, we show that genomic regions coding for the transient 
transcriptome recently described in T cells,22 are significantly enriched for both MS-associated 
GWAS variants, as well as for DNA binding sites for protein ‘transducers’ of non-genetic signals, 
chosen among those plausibly associated to MS. The colocalization of GWAS intervals and some 
DNA-binding factors involved in MS etiology has already been reported,18, 20 and here we reinforce 
this premise further suggesting a model in which trRNA-coding regions are hotspots of 
convergence between genetic ad non-genetic factors of risk/protection for MS. Our analysis 
showed that these hotspots are shared by two or more of the four nuclear factors, that we 
arbitrarily chose, indicating possible additive pathogenic effects for MS development (see Fig. 3 
and Supplementary Table 6). 
In homeostatic conditions, it can be hypothesized that DNA sequences coding for trRNA are 
composed of regulatory regions where genetic variability and non-genetic signals interact to finely 
regulate the gene expression according to cell identity, developmental or adaptive states, and 
time-dependent stimuli. As a matter of fact, the high sequence variability of these regions and the 
strict time-dependence of their transcription could be instrumental to adaptative features; however, 
these same features make these regions susceptible to become dysfunctional or to be the targets 
of pathogenic interaction. In some instances, these detrimental interactions come from outside the 
cell, such as in the case of EBV interference with host transcription,35, 42 and the pathogenic 
consequences of vitamin D deficiency; in other cases, the dysfunction develops within the cell, 
such as the tumorigenic activity of AID in B cells.43, 44 
The mapping of transient transcripts by TT-seq approach fits very well with our results obtained 
from GWAS data for MS and other multifactorial conditions, showing a significant excess of 
intergenic and intronic regions (coding for eRNA, sincRNA, and asRNA), and having a distribution 
in DNA intervals mostly far off from transcription start sites (TSS; see Fig. 1). This is in agreement 
with recent evidence of regulatory DNA region markers which contains genetic variants for 
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complex disease or traits; indeed, a systematic framework of common coordinates for these 
markers showed that about half of them lie within introns and most localize away from the TSS.11 
To further support the relationship between trRNA and transcription of regulatory DNA regions, we 
matched a large dataset of enhancers and super-enhancers with MS-GWAS signals and DBR for 
VDR, EBNA2, EBNA3C and AID. The significant enrichment in cell lines and cell status coming 
from the hematopoietic lineages and the CNS-specific cell subsets corroborates data coming from 
recent reports such as the relevance of contextualizing and prioritizing the role of MS-associated 
GWAS signals.31, 32, 45, 46 Our analysis supports the pivotal regulatory role of enhancer transcription 
(i.e., a main component of transient transcriptome) was recently reported as not dispensable for 
gene expression at the immunoglobulin locus and for antibody class switch recombination,47 
though more research is needed to unravel such topic at a finer grain.  
Reports on dynamics of time-course data are a recent area of focus within the analysis of gene 
expression, specifically in immune cells. Although current studies use methods that investigate 
time points related to the stable transcriptome (RNA-seq performed with time spans of hours), they 
clearly show that gene expression dynamics may influence allele specificity, regulatory programs 
that seem to depend on autoimmune disease-associated loci, and different transcriptional profiles 
based on cell status after stimulation.48 A recent work showed that an IL2ra enhancer, which 
harbors autoimmunity risk variants and was one of the first MS-associated loci from GWAS, has no 
impact on the gene level expression. In times of gene activation, the same IL2ra enhancer would 
be delaying transcription in response to extracellular stimuli.7 The importance of the timing in the 
gene expression control emerges also from several studies implicating enhancers and super-
enhancers in the process of phase separation and formation of condensates. In this context, the 
transcriptional apparatus steps-up to drive robust genic responses.49-52 The overall process seems 
to be highly dynamic, with time spans of seconds or minutes, and hence compatible with the 
temporal features of the transient transcriptome, which could somehow act upstream for the 
formation of these phase-separated condensates.  
We suggest that studies on transient transcriptomes may integrate previous RNA-seq data in 
accounting for the interplay between genetic variability and non-genetic etiologic factors leading to 
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MS development. Components of a more-complex-than-anticipated regulation of gene expression 
could include transcriptional noise, transitory time-courses, erratic dynamics, and highly flexibility 
of some DNA regions, possibly oscillating between bistable states of enhancer and silencer.53 The 
availability of tools to map trRNA could further contribute to the development of studies on immune 
cells isolated from patients and matched controls, aimed at dissecting key aspects of the complex 
transcriptional response in MS. Our analysis provides a platform for future studies on transient 
transcriptome, which we support by making our data resource available at www.mscoloc.com. 
Moreover, new gene regulatory models may emerge from this approach in order to better evaluate 
the meaning of GWAS in complex traits and the impact of the enhancer transcription,47 which was 
recently reported as an ancient and conserved, yet flexible, genomic regulatory syntax.54 
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DATA ANALYSIS 
Analyses were performed in Python and R. A data freeze was applied on 3/1/2020. All GWAS data 
was gathered from the GWAS Catalog through its REST API;30, 37 about 1.5% of this data was 
filtered out as part of a QC process aimed at homogenizing legacy and more recent data. The MS 
GWAS regions were extracted from the overall GWAS Catalog data filtering by trait EFO_0003885. 
All Transcription Factor Binding Site regions (TFBS) were obtained from the ENCODE portal.38 All 
data was organized in various databases and data pipelines as detailed below. For SNP overlaps 
and region colocalization, we used LOLA39 and Fisher’s exact test with False Discovery Rate 
(Benjamini-Hochberg) to control for multiple testing; this was containerized and modularized to 
work on a parallel cluster environment. Resulting -log(p-value), support, and Odds Ratio (OR) were 
combined into a single score inspired by the harmonic mean40 and multi-objective optimization41 
with the formula below, where the spacing parameter kp was set to 10.0 and we consider all three 
contributors equally, setting therefore weights wi to 1.0. Statistical significance was taken at 
p<0.05. A modular and parallel data pipeline was created to: (i) readily generate and evaluate all 
experiments in the paper, (ii) manage and organize all data coming from various region databases 
(10,000+ regions), multiple ROIs (MS GWAS, EBNA2, EBNA3C, VDR,  AID, etc.), databases of 
vast background regions as they were populated with the data obtained from GWAS Catalog, 
ENCODE, and other data resources, (iii) provide overlaps and intersection among various data 
elements, annotate them with the original MS GWAS loci that generated the signal, and (iv) 
generate the overarching data resource available at www.mscoloc.com. 
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Table 1. Enrichment of MS-associated genetic variants in lists of T-cell transient transcripts extracted from Michel et al.22 The whole 
transcriptome list was split in two sub-lists depending on the transcripts’ half-life: short (<60’) and long (≥60’), respectively. Results are considered 
significant at p<0.05 and are highlighted in bold. 
  
List 





Whole transient transcriptome 8.55 2.80 x 10-9 1.65 241 22126 41.3 
Short half-life transcripts 7.68 2.06 x 10 -8 1.63 209 20143 40.1 
Long half-life transcripts 1.05  0.09 1.29 35 1993 17.1 
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Table 2. Enrichment of MS-GWAS regions in lists of DNA binding sites of human and viral molecular transducers. For each molecular 
transducer, the number of DBRs is shown in brackets in the right-most column. Columns display the statistical analysis results derived from the 
colocalization analysis of the MS-associated genomic positions at different ranges of extension (±50,100,200 kb). Results are considered 




 ± 50 KB ± 100 KB ± 200 KB 
 -log 
























19.348 1.575 474 43.564 19.181 1.422 767 39.635 32.090 1.424 1329 40.872 
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Table 3. Colocalization of human and viral transducer DBRs and MS-GWAS positions in transient transcripts. MS-associated genomic 
positions were analyzed at different ranges of extension (±50,100, 200 kb). The transcript half-life is considered short if <60’ and long if ≥60’, 
respectively. Results are considered significant at p<0.05, corresponding to a -log(p)>1.301. Significant results are highlighted in bold.
  
 
± 50 KB ± 100 KB ± 200 KB 













(pValue) (pValue) (pValue) 
EBNA2 Long half-life 0.023 0.478 3 0.644 0.062 0.717 8 1.708 1.879 1.531 33 24.679 
  Short half-life 6.163 1.920 69 43.011 3.241 1.433 95 29.496 8.945 1.610 189 40.642 
EBNA3C Long half-life 0.064 0.572 2 1.669 0.006 0.321 2 0.185 0.182 0.914 11 4.500 
  Short half-life 0.070 0.794 16 1.923 0.023 0.752 28 0.661 0.066 0.875 58 1.841 
AID Long half-life 0.089 0.682 3 2.303 0.283 1.024 8 6.477 0.051 0.726 11 1.432 
  Short half-life 1.769 1.465 37 23.531 1.346 1.267 59 19.367 3.954 1.442 119 31.416 
VDR Long half-life 1.737 1.502 32 23.571 0.845 1.187 45 14.646 2.315 1.322 97 25.031 
  Short half-life 2.221 1.239 152 23.734 2.336 1.181 267 23.460 11.478 1.367 548 36.561 
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FIGURES 
 
Figure 1. GWAS-associated SNP distribution across genomic partitions and their distance 
relative to the transcription starting site (TSS). Panel A) Multiple Sclerosis; B) Immune-
mediated conditions: Multiple Sclerosis, Rheumatoid Arthritis, Systemic Lupus Erythematosus, 
Crohn’s Disease, Ulcerative Colitis, Inflammatory Bowel Disease, Celiac Disease, Asthma, Type I 
Diabetes Mellitus; C) Non-immunological complex conditions: Type II Diabetes Mellitus, Aging, 
Obesity, Hypertension, Coronary Artery Disease, Bipolar Disorder. Supplementary table 2 include 
links to these traits in the GWAS catalog. 
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Figure 2. Enrichment of MS-associated SNPs in databases of regulatory elements, sorted by 
experiment/cell lines. X-axis shows the Odd Ratio, y-axis shows the -log(pValue); dot size is 
proportional to the support of each match, i.e., the number of hits resulting from the colocalization 
analysis. Color of each point is related to the Harmonic Score (HS), a comprehensive estimation of 
the relevance of hits, as derived by merging and balancing the OR, pValue and Support of each 
match. Thus, prioritized hits are represented by the darker dots that occupy the upper-right area of 
the chart. Labeled points have HS>40. 
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Figure 3. MS-GWAS regions in DNA binding sites of human and viral molecular transducers.  This Venn diagram shows the number of non-
redundant MS-associated SNPs (from the ROI, supplementary table 1) and their extensions at ±50, 100, 200 kb that colocalized within DNA binding 
regions of the molecular transducers AID, VDR, EBNA2, EBNA3C. For each transducer, SNPs are considered only once if present in more than one 
match. Intersections show the numbers of regions colocalizing with DBRs of multiple transducers. For instance: 8 regions colocalize with both EBNA2 
and EBNA3C DBRs, but not with AID nor VDR DBRs; 24 regions colocalize with all four DBRs 
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Figure 4. Schematic representation of the colocalization analysis. (ROI: Region of interest; DBR: DNA Binding Regions; ENCODE TFBS: 
Transcription Factor Binding Site). The figure shows the tracks we considered for the colocalization analyses. In brief, the ROI included the DBRs of 
MS-related viral and human transducers and was matched with MS-associated SNPs extended by 50, 100, and 200 kilobases that colocalize with 
regions plausibly coding for trRNAs (Database). As a control (Universe), we took from ENCODE the entire list of transcription factors binding sites. 
Results were considered significant if a colocalization was found across ROI and a Databases element without occurring in the Universe as a 
statistically significant match. 
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Figure 5. Colocalization analysis of DBRs for human and viral molecular transducers, MS-
associated SNPs and DNA regulatory regions derived from databases. (A) EBNA2; (B) 
EBNA3C; (C) AID; (D) VDR. The charts display results of all matches, i.e. with MS-associated 
SNPs and their extension at ±50, 100, 200 kb. X-axis shows the Odd Ratio, y-axis shows the 
log(pValue). Dot size is proportional to the support of each match, i.e. the number of hits resulting 
from each colocalization analysis. The color of each dot is related to the Harmonic Score (HS); 
Labels are shown starting at HS>40. 
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Supplementary Figure 1. Harmonic Score threshold defining the top colocalization hits. The 
plot shows all of colocalization matches, ranked by Harmonic Score (HS). The curve inflection 
point, highlighted with a red line, suggests a threshold for selecting the most relevant hits (i.e., 
those scoring at HS>40).   
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